Menu

Brain Prize Laureate Will Donate Some Winnings to Anti-Brexit Group

Alzheimer’s researcher John Hardy calls the departure “an unmitigated disaster” for science and healthcare in Britain.

Mar 6, 2018
Shawna Williams

ISTOCK, ANDREJ_KAt a press conference today (March 6), one of the four winners of this year’s Brain Prize, University College London neuroscientist John Hardy, turned attention to the impact of Britain’s impending exit from the European Union on science and healthcare in the country. The expected exodus of healthcare workers from other European countries will strain the ability of the U.K.’s National Health Service to care for the growing number of patients with dementia, Hardy predicts.

As reported in The Guardian, Hardy shares the €1 million prize with Bart De Strooper, also of University College London; Michel Goedert of the Medical Research Council Laboratory of Molecular Biology in Cambridge, U.K.; and Christian Haass of the Ludwig-Maximilians-University in Munich, for their discoveries on the mechanisms underlying Alzheimer’s disease.

See “Do Microbes Trigger Alzheimer’s Disease?

“When you go around the hospitals, so many of the geriatricians and neurologists are Europeans, and the nurses and carers,” Hardy said during the press conference (via The Guardian). “As a society we’re not doing very well, and the indications are we’re going to do even worse.” The BBC reports that he plans to donate about €5,000 to groups striving to keep Britain in the E.U.

Hardy is far from the first to predict dire consequences of Brexit for health and science. Ahead of the 2016 referendum on whether to remain in the E.U., for example, Nature found that 83 percent of researchers favored staying.

November 2018

Intelligent Science

Wrapping our heads around human smarts

Marketplace

Sponsored Product Updates

Slice® Safety Cutters for Lab Work

Slice® Safety Cutters for Lab Work

Slice cutting tools—which feature our patent-pending safety blades—meet many lab-specific requirements. Our scalpels and craft knives are well suited for delicate work, and our utility knives are good for general use.

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

The Lab of the Future: Alinity Poised to Reinvent Clinical Diagnostic Testing and Help Improve Healthcare

Every minute counts when waiting for accurate diagnostic test results to guide critical care decisions, making today's clinical lab more important than ever. In fact, nearly 70 percent of critical care decisions are driven by a diagnostic test.

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC announces new, integrated, global portfolio brand, Biosearch Technologies, representing genomic tools for mission critical customer applications

LGC’s Genomics division announced it is transforming its branding under LGC, Biosearch Technologies, a unified portfolio brand integrating optimised genomic analysis technologies and tools to accelerate scientific outcomes.